• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4616374)   Today's Articles (686)   Subscriber (49394)
For: Gibbs J, Grover A, Emery M, Dodds M, Somaratne R, Wasserman S. Impact of target-mediated elimination on evolocumab dose and regimen. Atherosclerosis 2015. [DOI: 10.1016/j.atherosclerosis.2015.04.956] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Number Cited by Other Article(s)
1
Evolocumab: First Global Approval. Drugs 2016;75:1567-73. [PMID: 26323342 DOI: 10.1007/s40265-015-0460-4] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
2
Keating GM. Evolocumab: A Review in Hyperlipidemia. Am J Cardiovasc Drugs 2016;16:67-78. [PMID: 26643308 DOI: 10.1007/s40256-015-0153-0] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA